Statistics show that stress and burnout are affecting more women than men en masse. Why – and what happens next?
When Jia, a Manhattan-based consultant, read Sheryl Sandberg’s bestselling book Lean In in 2014, she resolved to follow the advice espoused by the chief operating officer of Facebook.
“I’d just graduated from an Ivy League business school, was super pumped up and loved the idea of leaning in,” says Jia, whose last name is being withheld to protect her professional reputation. “Learning to self-promote felt so empowering, and I was 100% ready to prove that I was the woman who could have it all: be a high-powered career woman and a great mother.”
But today, the 38-year-old strikes a different tone. For years, she says, she feels like she’s been overlooked for promotions and pay rises at work on account of her gender, particularly after becoming a mother in 2018. Since then, she’s picked up the brunt of childcare responsibilities because her husband, who is a banker, has tended to travel more frequently for work. That, she adds, has given her a misguided reputation among her colleagues and managers – the majority of whom are male – for not being professionally driven.
Then when Covid-19 hit, it was as if all the factors already holding her back were supercharged. When her daughter’s day care closed in March 2020, Jia became the default caregiver while trying to stay afloat at work. “I was extremely unmotivated because I felt like I was spending all hours of the day trying not to fall off an accelerating treadmill,” she explains. “But at the same time, I felt like I was being trusted less and less to be able to do a good job. I could feel my career slipping through my fingers and there was absolutely nothing I could do about it.”
In early 2021, Jia’s therapist told her she was suffering from burnout. Jia says she’d never struggled with her mental health before. “But now I’m just trying to get through each week while staying sane,” she says.
Jia’s story is symptomatic of a deeply ingrained imbalance in society that the pandemic has both highlighted and exacerbated. For multiple reasons, women, particularly mothers, are still more likely than men to manage a more complex set of responsibilities on a daily basis – an often-unpredictable combination of unpaid domestic chores and paid professional work.
I could feel my career slipping through my fingers and there was absolutely nothing I could do about it – Jia
Though the mental strain of mastering this balancing act has been apparent for decades, Covid-19 has cast a particularly harsh light on the problem. Statistics show that stress and burnout are affecting more women than men, and particularly more working mothers than working fathers. This could have multiple impacts for the post-pandemic world of work, making it important that both companies and wider society find ways to reduce this imbalance.
Recent data looking specifically at burnout in women is concerning. According to a survey by LinkedIn of almost 5,000 Americans, 74% of women said they were very or somewhat stressed for work-related reasons, compared with just 61% of employed male respondents.
A separate analysis from workplace-culture consultancy a Great Place to Work and health-care start-up Maven found that mothers in paid employment are 23% more likely to experience burnout than fathers in paid employment. An estimated 2.35 million working mothers in the US have suffered from burnout since the start of the pandemic, specifically “due to unequal demands of home and work”, the analysis showed.
Women tend to be dealing with a more complex set of work and personal responsibilities, leading to stress (Credit: Getty)
Experts generally agree that there’s no single reason women burn out, but they widely acknowledge that the way societal structures and gender norms intersect plays a significant role. Workplace inequalities, for example, are inextricably linked to traditional gender roles.
In the US, women still earn an average of about 82 cents for each dollar earned by a man, and the gap across many countries in Europe is similar. Jia’s firm does not publish its gender pay-gap data, but she suspects that it’s significant. Moreover, she thinks many of her male peers earn more than her, something that causes her a huge amount of stress.
“The idea that I might be underselling myself is extremely frustrating, but I also don’t want to make myself unpopular by asking for more money when I’m already pushing the boundaries by asking my company to make accommodations for me having to care for my daughter,” she says. “It’s a constant internal battle.”
Research links lower incomes to higher stress levels and worse mental health in general. But several studies have also shown more specifically that incidences of burnout among women are greater because of differences in job conditions and the impact of gender on progression.
In 2018, researchers from University of Montreal published a study tracking 2,026 workers over the course of four years. The academics concluded that women were more vulnerable to burnout than men because women were less likely to be promoted than men, and therefore more likely to be in positions with less authority which can lead to increased stress and frustration. The researchers also found that women were more likely to head single-parent families, experience child-related strains, invest time in domestic tasks and have lower self-esteem – all things that can exacerbate burnout.
Nancy Beauregard, a professor at University of Montreal and one of the authors of that study, said that reflecting on her work back in 2018, it’s clear that Covid-19 has amplified the existing inequalities and imbalances that her team demonstrated through their research. “In terms of [the] sustainable development of the human capital of the workforce,” she says, “we’re not heading in a good direction.”
A pandemic catalyst
Brian Kropp, chief of human resources research at Gartner, a global research and advisory firm headquartered in Connecticut, US, agrees that while many of the factors fueling women’s burnout were in play before the pandemic, Covid-19 notably exacerbated some as it forced us to dramatically overhaul our living and working routines.
When the pandemic hit, many women found that their domestic responsibilities surged – making juggling work even harder (Credit: Getty)
Structures supporting parents’ and carers’ lives closed down, and in most cases, this excess burden fell on women. One study, conducted by academics from Harvard University, Harvard Business School and London Business School, evaluated survey responses from 30,000 individuals around the world and found that women – especially mothers – had spent significantly more time on childcare and chores during Covid-19 than they did pre-pandemic, and that this was directly linked to lower wellbeing. Many women had already set themselves up as the default caregiver within their households, and the pandemic obliterated the support systems that had previously allowed them to balance paid employment and domestic work.
That’s exactly what Sarah experienced in March 2020, when schools across New York first closed. “Initially the message was that schools would stay closed until the end of April, so that was my target: ‘Get to that point and you’ll be fine’,” recalls the Brooklyn-based 40-year-old. Now, more than 18 months into the pandemic, her two sons, aged 6 and 9, are only just reacquainting themselves with in-person learning, and Sarah’s life has changed dramatically.
In April 2020, for the first time ever, she started suffering from anxiety. The pressures of home-schooling her children while working as marketing executive for a large technology company overwhelmed her. She couldn’t sleep, worried constantly and felt depressed. Worst of all, she felt like whatever she did was inadequate because she didn’t have enough time to do anything well.
Six months into the pandemic, it was clear something had to change. Sarah’s husband, a lawyer, was earning much more than her, and had done so since they got married in 2008. So, in August 2020 the couple jointly decided that Sarah would leave her job to become a stay-at-home mother. “Before this, I never really knew what being burned out meant,” she says. “Now I know beyond a shadow of a doubt.”
Sarah’s experience is emblematic of a much broader trend. In September last year, just as the pandemic was gaining pace, more than 860,000 women dropped out of the US workforce, compared with just over 200,000 men. One estimate put the number of mothers who had quit the US workforce between February and September last year at 900,000, and the number of fathers at 300,000.
As women lost crucial social lifelines during lockdown which may have been emotional and physical outlets for stress, it’s clear that the abrupt avalanche of extra domestic responsibilities pushed many who were already busily juggling home and work life further than they could go.
‘What’s the cost?’
One of the greatest concerns workplace experts harbour is that poor mental health among women in the workplace could discourage future generations from setting ambitious professional goals, particularly if they want to start a family. That could exacerbate the gender inequalities that already exist in terms of pay and seniority in the labour market.
Data indicate that this is indeed a legitimate concern; statistics collected by CNBC and polling company SurveyMonkey earlier this year showed that the number of women describing themselves as “very ambitious” in terms of their careers declined significantly during the pandemic. Data from the US Census Bureau shows that over the first 12 weeks of the pandemic, the percentage of mothers between the ages of 25 and 44 not working due to Covid-19-related childcare issues grew by 4.8 percentage points, compared to no increase for men in the same age group.
In terms of [the] sustainable development of the human capital of the workforce, we’re not heading in a good direction – Nancy Beauregard
Equally, there are concerns about how new ways of working such as hybrid could impact on workplace gender equality. Research shows that women are more likely than men to work from home in a post-pandemic world, but there’s evidence that people who work from home are less likely to get promoted than those who have more face-time with managers. “Women are saying, I’m working just as hard and doing just as much, but because I’m working from home, I’m less likely to get promoted,” says Kropp. “That’s extremely demotivating.”
Dean Nicholson, head of adult therapy at London-based behavioural health clinic The Soke, suggests that perceptions of fairness – or otherwise – could impact on women’s workplace participation. “When the balance of justice is skewed against us in the workplace, then it’s invariably going to lead to negative feelings, not just towards the organisation, but in the way that we feel about ourselves and the value of our contribution, as well as where we’re positioned on a hierarchy of worth.”
To prevent an exodus of female talent, says Kropp, organisations must appreciate that old workplaces practices are no longer fit for purpose. Managers need to fundamentally rethink how companies must be structured in order to promote fairness and equality of opportunity, he says. That means pay equality and equal opportunities for promotion, as well as creating a culture of transparency where everyone – mothers, fathers and employees who are not parents – feels valued and can reach their professional potential while also accommodating what’s going on at home.
Steve Hatfield, global future of work leader for Deloitte, notes that mothers, especially those in senior leadership roles, are extremely important role models. “The ripple effect of what they’re seen to be experiencing right now has the potential to be truly profound on newer employees, and so it’s up to organisations to prove that they can accommodate and cater to the needs of all employees,” he says.
As such, Hephzi Pemberton, founder of the Equality Group, a London-based consultancy that focuses on inclusion and diversity in the finance and technology industry, emphasises the need for managers to be trained formally and to understand that the initiative to create a workplace that’s fit for purpose must come from the employer rather than the employee. “That’s absolutely critical to avoid the risk of burnout,” she says.
But Jia, who says she’s now on the brink of quitting her job, insists that notable changes need to happen in the home as well as the workplace. “What’s become abundantly clear to me through the pandemic is that we all have a role to play in understanding the imbalances that are created when stereotypical gender roles are blindly adhered to,” she says. “Yes, of course it sometimes makes sense for a woman to be the default caregiver or to take a step back from paid work, but we need to appreciate at what cost. This is 2021. Sometimes I wonder if we’re in the 1950s.”
By Josie Cox
- “Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) | CDC”. http://www.cdc.gov. 2020-04-13. Archived from the original on 2020-08-22. Retrieved 2020-05-20.
- Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome; Board on the Health of Select Populations; Institute of, Medicine (10 February 2015). Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness (PDF). PMID 25695122. Archived (PDF) from the original on 20 January 2017. Retrieved 28 July 2020.
- “Epidemiology | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) | CDC”. http://www.cdc.gov. 2018-07-12. Archived from the original on 2020-06-06. Retrieved 2020-05-24.
- “What is ME/CFS? | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) | CDC”. http://www.cdc.gov. 2018-07-12. Archived from the original on 2020-08-17. Retrieved 2020-05-21.
- “Possible Causes | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) | CDC”. http://www.cdc.gov. 15 May 2019. Archived from the original on 22 August 2020. Retrieved 20 May 2020.
- Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, Staines D, Powles ACP, Speight N, Vallings R, Bateman L, Bell DS, Carlo-Stella N, Chia J, Darragh A, Gerken A, Jo D, Lewis D, Light AR, Light K, Marshall-Gradisnik S, McLaren-Howard J, Mena I, Miwa K, Murovska M, Steven S (2012). Myalgic Encephalomyelitis – Adult & Paediatric: International Consensus Primer for Medical Practitioners Authors – International Consensus Panel. Archived 2020-07-10 at the Wayback Machine
- “Treatment of ME/CFS | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) | CDC”. http://www.cdc.gov. 2019-11-19. Archived from the original on 2021-03-20. Retrieved 2020-05-22. ‹See TfM› This article incorporates text from this source, which is in the public domain.
- Cochrane (21 May 2020). “Publication of Cochrane Review: ‘Exercise therapy for chronic fatigue syndrome‘“. http://www.cochrane.org. Archived from the original on 2020-06-17. Retrieved 2020-05-24.
It now places more emphasis on the limited applicability of the evidence to definitions of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) used in the included studies, the long-term effects of exercise on symptoms of fatigue, and acknowledges the limitations of the evidence about harms that may occur.
- Sandler, Carolina X; Lloyd, Andrew R (2020). “Chronic fatigue syndrome: progress and possibilities”. Medical Journal of Australia. 212 (9): 428–33. doi:10.5694/mja2.50553. ISSN 0025-729X. PMID 32248536. S2CID 214810583.
- Lim EJ, Ahn YC, Jang ES, Lee SW, Lee SH, Son CG (February 2020). “Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)”. J Transl Med. 18 (1): 100. doi:10.1186/s12967-020-02269-0. PMC 7038594. PMID 32093722.
- “Information for Healthcare Providers | CDC”. http://www.cdc.gov. 2020-04-13. Archived from the original on 2020-08-09. Retrieved 2020-06-17.
- Dibble, Joshua J; McGrath, Simon J; Ponting, Chris P (2020-09-30). “Genetic risk factors of ME/CFS: a critical review”. Human Molecular Genetics. 29 (R1): R117–R124. doi:10.1093/hmg/ddaa169. PMC 7530519. PMID 32744306.
- “Symptoms of ME/CFS | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) | CDC”. http://www.cdc.gov. 2019-11-19. Archived from the original on 2020-08-22. Retrieved 2020-05-20.
- “Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) | CDC”. http://www.cdc.gov. 2020-04-13. Retrieved 2020-05-20.
- Afari N, Buchwald D (February 2003). “Chronic fatigue syndrome: a review”. The American Journal of Psychiatry. 160 (2): 221–36. doi:10.1176/appi.ajp.160.2.221. PMID 12562565.
- Estévez-López, Fernando; Mudie, Kathleen; Wang-Steverding, Xia; Bakken, Inger Johanne; Ivanovs, Andrejs; Castro-Marrero, Jesús; Nacul, Luis; Alegre, Jose; Zalewski, Paweł; Słomko, Joanna; Strand, Elin Bolle; Pheby, Derek; Shikova, Evelina; Lorusso, Lorenzo; Capelli, Enrica; Sekulic, Slobodan; Scheibenbogen, Carmen; Sepúlveda, Nuno; Murovska, Modra; Lacerda, Eliana (2020-05-21). “Systematic Review of the Epidemiological Burden of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Across Europe: Current Evidence and EUROMENE Research Recommendations for Epidemiology”. Journal of Clinical Medicine. MDPI AG. 9 (5): 1557. doi:10.3390/jcm9051557. ISSN 2077-0383. PMC 7290765. PMID 32455633.
- Ranjith G (January 2005). “Epidemiology of chronic fatigue syndrome”. Occupational Medicine. 55 (1): 13–19. doi:10.1093/occmed/kqi012. PMID 15699086.
- “Severely Affected Patients – Clinical Care of Patients – Healthcare Providers – Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)”. CDC. 2019-11-19. Archived from the original on 2020-12-11. Retrieved 2020-11-30.
- “Guidance – Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): diagnosis and management”. NICE. 2007-08-22. Archived from the original on 2020-07-12. Retrieved 2020-07-11.
- Smith ME, Haney E, McDonagh M, Pappas M, Daeges M, Wasson N, Fu R, Nelson HD (June 2015). “Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop”. Annals of Internal Medicine (Systematic review). 162 (12): 841–50. doi:10.7326/M15-0114. PMID 26075755.
- “Annex 1: Epidemiology of CFS/ME”. UK Department of Health. 2012-01-06. Archived from the original on 2012-01-06. Retrieved July 28, 2017.
- “ME/CFS in Children | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) | CDC”. http://www.cdc.gov. 2019-05-15. Archived from the original on 2020-07-28. Retrieved 2020-05-24.
ME/CFS is often thought of as a problem in adults, but children (both adolescents and younger children) can also get ME/CFS.
- Ottati VC (2002). The social psychology of politics. New York: Kluwer Academic/Plenum. pp. 159–60. ISBN 978-0-306-46723-3. Archived from the original on 2021-02-14. Retrieved 2009-08-11.
- Price JR, Mitchell E, Tidy E, Hunot V (July 2008). Price JR (ed.). “Cognitive behaviour therapy for chronic fatigue syndrome in adults”. The Cochrane Database of Systematic Reviews. 2021 (3): CD001027. doi:10.1002/14651858.CD001027.pub2. PMC 7028002. PMID 18646067.
- “Treating the Most Disruptive Symptoms First and Preventing Worsening of Symptoms | CDC”. http://www.cdc.gov. 2019-11-19. Archived from the original on 2020-08-07. Retrieved 2020-08-19.
- “CDC – Chronic Fatigue Syndrome (CFS) – Diagnosis”. Cdc.gov. Archived from the original on 2012-08-05. Retrieved 2012-07-22.
- “CDC, Chronic Fatigue Syndrome (CFS), Making a Diagnosis” (PDF). Cdc.gov. Archived (PDF) from the original on 2011-10-16. Retrieved 2011-01-28.
- Nijs J, Meeus M, Van Oosterwijck J, Ickmans K, Moorkens G, Hans G, De Clerck LS (February 2012). “In the mind or in the brain? Scientific evidence for central sensitisation in chronic fatigue syndrome”. European Journal of Clinical Investigation. 42 (2): 203–12. doi:10.1111/j.1365-2362.2011.02575.x. PMID 21793823. S2CID 13926525.
- Vanness JM, Snell CR, Strayer DR, Dempsey L, Stevens SR (June 2003). “Subclassifying chronic fatigue syndrome through exercise testing”. Medicine and Science in Sports and Exercise. 35 (6): 908–13. doi:10.1249/01.MSS.0000069510.58763.E8. PMID 12783037.
- Ross SD, Estok RP, Frame D, Stone LR, Ludensky V, Levine CB (May 2004). “Disability and chronic fatigue syndrome: a focus on function”. Archives of Internal Medicine. 164 (10): 1098–107. doi:10.1001/archinte.164.10.1098. PMID 15159267.
- “Presentation and Clinical Course of ME/CFS | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) | CDC”. http://www.cdc.gov. 2019-11-19. Archived from the original on 2020-07-28. Retrieved 2020-07-11.
- Ho-Yen DO, McNamara I (August 1991). “General practitioners’ experience of the chronic fatigue syndrome”. The British Journal of General Practice. 41 (349): 324–26. PMC 1371754. PMID 1777276.
- Meeus M, Nijs J, Meirleir KD (May 2007). “Chronic musculoskeletal pain in patients with the chronic fatigue syndrome: a systematic review”. European Journal of Pain. 11 (4): 377–86. doi:10.1016/j.ejpain.2006.06.005. PMID 16843021. S2CID 21414690.
- McCully KK, Sisto SA, Natelson BH (January 1996). “Use of exercise for treatment of chronic fatigue syndrome”. Sports Medicine. 21 (1): 35–48. doi:10.2165/00007256-199621010-00004. PMID 8771284. S2CID 239650.
- Burton C, Knoop H, Popovic N, Sharpe M, Bleijenberg G (June 2009). “Reduced complexity of activity patterns in patients with chronic fatigue syndrome: a case control study”. BioPsychoSocial Medicine. 3 (1): 7. doi:10.1186/1751-0759-3-7. PMC 2697171. PMID 19490619.
- Solomon L, Nisenbaum R, Reyes M, Papanicolaou DA, Reeves WC (October 2003). “Functional status of persons with chronic fatigue syndrome in the Wichita, Kansas, population”. Health and Quality of Life Outcomes. 1 (1): 48. doi:10.1186/1477-7525-1-48. PMC 239865. PMID 14577835.
- Mark, Loveless, MD, congressional testimony of, May 12, 1995, as reported in Hillary Johnson. (1996). Osler’s Web: Inside the Labyrinth of the Chronic Fatigue Syndrome Epidemic. Crown Publishers, New York. ISBN 0-517-70353-X. pp. 364–65
- “Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)”. Centers for Disease Control and Prevention. 13 April 2020. Archived from the original on 26 June 2020. Retrieved 1 June 2020.
- Anderson JS, Ferrans CE (June 1997). “The quality of life of persons with chronic fatigue syndrome”. The Journal of Nervous and Mental Disease. 185 (6): 359–67. doi:10.1097/00005053-199706000-00001. PMID 9205421.
- Komaroff AL, Fagioli LR, Doolittle TH, Gandek B, Gleit MA, Guerriero RT, Kornish RJ, Ware NC, Ware JE, Bates DW (September 1996). “Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups”. The American Journal of Medicine. 101 (3): 281–90. doi:10.1016/S0002-9343(96)00174-X. PMID 8873490.
- “Chronic Fatigue Syndrome: Advancing Research and Clinical Education”. Centers for Disease Control and Prevention. 28 February 2018. Archived from the original on 28 July 2020. Retrieved 26 May 2020.
- Unger ER, Lin JS, Brimmer DJ, Lapp CW, Komaroff AL, Nath A, Laird S, Iskander J (December 2016). “CDC Grand Rounds: Chronic Fatigue Syndrome – Advancing Research and Clinical Education” (PDF). MMWR. Morbidity and Mortality Weekly Report. 65 (50–51): 1434–38. doi:10.15585/mmwr.mm655051a4. PMID 28033311. Archived (PDF) from the original on 2017-01-06. Retrieved 2017-01-05.
- Christley, Y; Duffy, T; Everall, IP; Martin, CR (2013). “The neuropsychiatric and neuropsychological features of chronic fatigue syndrome: revisiting the enigma”. Current Psychiatry Reports. 15 (4): 353. doi:10.1007/s11920-013-0353-8. ISSN 1523-3812. PMID 23440559. S2CID 25790262.
- Cvejic, Erin; Birch, Rachael C.; Vollmer-Conna, Uté (2016-03-31). “Cognitive Dysfunction in Chronic Fatigue Syndrome: a Review of Recent Evidence”. Current Rheumatology Reports. Springer Science and Business Media LLC. 18 (5): 24. doi:10.1007/s11926-016-0577-9. ISSN 1523-3774. PMID 27032787. S2CID 38748839.
- Rasa S, Nora-Krukle Z, Henning N, Eliassen E, Shikova E, Harrer T, Scheibenbogen C, Murovska M, Prusty BK (October 2018). “Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)”. J Transl Med. 16 (1): 268. doi:10.1186/s12967-018-1644-y. PMC 6167797. PMID 30285773.
- Gerwyn M, Maes M (January 2017). “Mechanisms Explaining Muscle Fatigue and Muscle Pain in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a Review of Recent Findings”. Current Rheumatology Reports. 19 (1): 1. doi:10.1007/s11926-017-0628-x. PMID 28116577. S2CID 11823204.
- “Chronic fatigue syndrome (Tapanui flu)”. http://www.southerncross.co.nz Southern Cross NZ. March 2020. Archived from the original on 30 January 2021. Retrieved 3 February 2021.
- Dinos S, Khoshaba B, Ashby D, White PD, Nazroo J, Wessely S, Bhui KS (December 2009). “A systematic review of chronic fatigue, its syndromes and ethnicity: prevalence, severity, co-morbidity and coping”. International Journal of Epidemiology. 38 (6): 1554–70. doi:10.1093/ije/dyp147. PMID 19349479.
- Van Houdenhove B, Kempke S, Luyten P (June 2010). “Psychiatric aspects of chronic fatigue syndrome and fibromyalgia”. Current Psychiatry Reports. 12 (3): 208–14. doi:10.1007/s11920-010-0105-y. PMID 20425282. S2CID 19669971.
- Hempel S, Chambers D, Bagnall AM, Forbes C (July 2008). “Risk factors for chronic fatigue syndrome/myalgic encephalomyelitis: a systematic scoping review of multiple predictor studies”. Psychological Medicine. 38 (7): 915–26. doi:10.1017/S0033291707001602. PMID 17892624. S2CID 20277129.
- Lievesley K, Rimes KA, Chalder T (April 2014). “A review of the predisposing, precipitating and perpetuating factors in Chronic Fatigue Syndrome in children and adolescents”. Clinical Psychology Review (Submitted manuscript). 34 (3): 233–48. doi:10.1016/j.cpr.2014.02.002. PMID 24632047. Archived from the original on 2020-07-28. Retrieved 2018-11-07.
- Cho HJ, Hotopf M, Wessely S (2005). “The placebo response in the treatment of chronic fatigue syndrome: a systematic review and meta-analysis”. Psychosomatic Medicine. 67 (2): 301–13. doi:10.1097/01.psy.0000156969.76986.e0. PMID 15784798. S2CID 33633322.
- “Myalgic Encephalomyelitis/Chronic Fatigue Syndrome – Etiology and Pathophysiology”. 2018-07-10. Archived from the original on 2018-07-18. Retrieved 2018-07-18.
- “Mortality and Morbidity Statistics”. ICD-11. Archived from the original on 2018-08-01. Retrieved 2021-01-09.
- Eriksen, Willy (16 August 2018). “ME/CFS, case definition, and serological response to Epstein-Barr virus. A systematic literature review”. Fatigue: Biomedicine, Health & Behavior. 6 (4): 220–34. doi:10.1080/21641846.2018.1503125. S2CID 80898744.
- Cleare AJ (March 2004). “The HPA axis and the genesis of chronic fatigue syndrome”. Trends in Endocrinology and Metabolism. 15 (2): 55–59. doi:10.1016/j.tem.2003.12.002. PMID 15036250. S2CID 1353041.
- Jason, Leonard A.; Porter, Nicole; Brown, Molly; Anderson, Valerie; Brown, Abigail; Hunnell, Jessica; Lerch, Athena (2009). “CFS: A Review of Epidemiology and Natural History Studies”. Bulletin of the IACFS/ME. 17 (3): 88–106. PMC 3021257. PMID 21243091.
- Hulme, Katrin; Hudson, Joanna L.; Rojczyk, Philine; Little, Paul; Moss-Morris, Rona (August 2017). “Biopsychosocial risk factors of persistent fatigue after acute infection: A systematic review to inform interventions” (PDF). Journal of Psychosomatic Research. 99: 120–29. doi:10.1016/j.jpsychores.2017.06.013. PMID 28712416. Archived (PDF) from the original on 2020-05-08. Retrieved 2020-05-26.
- Brurberg KG, Fønhus MS, Larun L, Flottorp S, Malterud K (February 2014). “Case definitions for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review”. BMJ Open. 4 (2): e003973. doi:10.1136/bmjopen-2013-003973. PMC 3918975. PMID 24508851.
- “ICD-11 – Mortality and Morbidity Statistics”. icd.who.int. Archived from the original on 1 August 2018. Retrieved 20 May 2020.
Diseases of the nervous system
- Maksoud R, du Preez S, Eaton-Fitch N, Thapaliya K, Barnden L, Cabanas H, Staines D, Marshall-Gradisnik S (2020). “A systematic review of neurological impairments in myalgic encephalomyelitis/ chronic fatigue syndrome using neuroimaging techniques”. PLOS ONE. 15 (4): e0232475. Bibcode:2020PLoSO..1532475M. doi:10.1371/journal.pone.0232475. PMC 7192498. PMID 32353033.
- Jason LA, Zinn ML, Zinn MA (2 February 2017). “Myalgic Encephalomyelitis: Symptoms and Biomarkers”. Current Neuropharmacology. 13 (5): 701–34. doi:10.2174/1570159X13666150928105725. PMC 4761639. PMID 26411464.
Decreased frontal grey matter
- Martínez-Martínez LA, Mora T, Vargas A, Fuentes-Iniestra M, Martínez-Lavín M (April 2014). “Sympathetic nervous system dysfunction in fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and interstitial cystitis: a review of case-control studies”. Journal of Clinical Rheumatology. 20 (3): 146–50. doi:10.1097/RHU.0000000000000089. PMID 24662556. S2CID 23799955.
- Jackson ML, Bruck D (December 2012). “Sleep abnormalities in chronic fatigue syndrome/myalgic encephalomyelitis: a review”. Journal of Clinical Sleep Medicine. 8 (6): 719–28. doi:10.5664/jcsm.2276. PMC 3501671. PMID 23243408.
- Tanaka M, Tajima S, Mizuno K, Ishii A, Konishi Y, Miike T, Watanabe Y (November 2015). “Frontier studies on fatigue, autonomic nerve dysfunction, and sleep-rhythm disorder”. The Journal of Physiological Sciences. 65 (6): 483–98. doi:10.1007/s12576-015-0399-y. PMC 4621713. PMID 26420687.
- Van Cauwenbergh D, Nijs J, Kos D, Van Weijnen L, Struyf F, Meeus M (May 2014). “Malfunctioning of the autonomic nervous system in patients with chronic fatigue syndrome: a systematic literature review”. European Journal of Clinical Investigation. 44 (5): 516–26. doi:10.1111/eci.12256. PMID 24601948. S2CID 9722415.
- Lapp, Charles W. (16 February 2016). “Chronic Fatigue Syndrome: Advancing Research and Clinical Education” (PDF). CDC Public Health Grand Rounds. Centers for Disease Control and Prevention. Archived (PDF) from the original on 18 October 2020. Retrieved 26 May 2020.
- Nijs J, Nees A, Paul L, De Kooning M, Ickmans K, Meeus M, Van Oosterwijck J (2014). “Altered immune response to exercise in patients with chronic fatigue syndrome/myalgic encephalomyelitis: a systematic literature review”. Exercise Immunology Review. 20: 94–116. PMID 24974723.
- Armstrong, Christopher W.; McGregor, Neil R.; Butt, Henry L.; Gooley, Paul R. (2014). Metabolism in Chronic Fatigue Syndrome. Advances in Clinical Chemistry. 66. pp. 121–72. doi:10.1016/B978-0-12-801401-1.00005-0. ISBN 978-0-12-801401-1. PMID 25344988.
- Morris G, Anderson G, Galecki P, Berk M, Maes M (March 2013). “A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and sickness behavior”. BMC Medicine. 11: 64. doi:10.1186/1741-7015-11-64. PMC 3751187. PMID 23497361.
- Griffith JP, Zarrouf FA (2008). “A systematic review of chronic fatigue syndrome: don’t assume it’s depression”. Primary Care Companion to the Journal of Clinical Psychiatry. 10 (2): 120–28. doi:10.4088/pcc.v10n0206. PMC 2292451. PMID 18458765.
- Meeus M, Mistiaen W, Lambrecht L, Nijs J (November 2009). “Immunological similarities between cancer and chronic fatigue syndrome: the common link to fatigue?”. Anticancer Research. 29 (11): 4717–26. PMID 20032425.
- Silverman MN, Heim CM, Nater UM, Marques AH, Sternberg EM (May 2010). “Neuroendocrine and immune contributors to fatigue”. PM & R. 2 (5): 338–46. doi:10.1016/j.pmrj.2010.04.008. PMC 2933136. PMID 20656615.
- Morris G, Anderson G, Maes M (November 2017). “Hypothalamic-Pituitary-Adrenal Hypofunction in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) as a Consequence of Activated Immune-Inflammatory and Oxidative and Nitrosative Pathways”. Molecular Neurobiology. 54 (9): 6806–19. doi:10.1007/s12035-016-0170-2. PMID 27766535. S2CID 3524276.
- Cho HJ, Skowera A, Cleare A, Wessely S (January 2006). “Chronic fatigue syndrome: an update focusing on phenomenology and pathophysiology”. Current Opinion in Psychiatry. 19 (1): 67–73. doi:10.1097/01.yco.0000194370.40062.b0. PMID 16612182. S2CID 12815707.
- Papadopoulos AS, Cleare AJ (September 2011). “Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome”. Nature Reviews. Endocrinology. 8 (1): 22–32. doi:10.1038/nrendo.2011.153. PMID 21946893. S2CID 22176725.
- Tak LM, Cleare AJ, Ormel J, Manoharan A, Kok IC, Wessely S, Rosmalen JG (May 2011). “Meta-analysis and meta-regression of hypothalamic-pituitary-adrenal axis activity in functional somatic disorders”. Biological Psychology. 87 (2): 183–94. doi:10.1016/j.biopsycho.2011.02.002. PMID 21315796. S2CID 206108463.
- Van Den Eede F, Moorkens G, Van Houdenhove B, Cosyns P, Claes SJ (2007). “Hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome”. Neuropsychobiology. 55 (2): 112–20. CiteSeerX 10.1.1.626.9632. doi:10.1159/000104468. PMID 17596739. S2CID 14956850.
- Powell DJ, Liossi C, Moss-Morris R, Schlotz W (November 2013). “Unstimulated cortisol secretory activity in everyday life and its relationship with fatigue and chronic fatigue syndrome: a systematic review and subset meta-analysis”. Psychoneuroendocrinology. 38 (11): 2405–22. doi:10.1016/j.psyneuen.2013.07.004. PMID 23916911.
- Morris G, Berk M, Galecki P, Maes M (April 2014). “The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs)”. Molecular Neurobiology. 49 (2): 741–56. doi:10.1007/s12035-013-8553-0. hdl:11343/219795. PMID 24068616. S2CID 13185036.
- Loebel, Madlen; Grabowski, Patricia; Heidecke, Harald; Bauer, Sandra; Hanitsch, Leif G.; Wittke, Kirsten; Meisel, Christian; Reinke, Petra; Volk, Hans-Dieter (Feb 2016). “Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome”. Brain, Behavior, and Immunity. 52: 32–39. doi:10.1016/j.bbi.2015.09.013. ISSN 1090-2139. PMID 26399744.
- Sotzny, Franziska; Blanco, Julià; Capelli, Enrica; Castro-Marrero, Jesús; Steiner, Sophie; Murovska, Modra; Scheibenbogen, Carmen; European Network on ME/CFS (EUROMENE) (2018). “Myalgic Encephalomyelitis/Chronic Fatigue Syndrome – Evidence for an autoimmune disease”. Autoimmunity Reviews. 17 (6): 601–09. doi:10.1016/j.autrev.2018.01.009. ISSN 1568-9972. PMID 29635081.
- Wirth, Klaus; Scheibenbogen, Carmen (2020-06-01). “A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Recognitions from the finding of autoantibodies against ß2-adrenergic receptors”. Autoimmunity Reviews. 19 (6): 102527. doi:10.1016/j.autrev.2020.102527. ISSN 1568-9972. PMID 32247028.
- Marshall-Gradisnik, Sonya; Smith, Peter; Nilius, Bernd; Staines, Donald R. (2015-01-01). “Examination of Single Nucleotide Polymorphisms in Acetylcholine Receptors in Chronic Fatigue Syndrome Patients”. Immunology and Immunogenetics Insights. 7: III.S25105. doi:10.4137/III.S25105. ISSN 1178-6345.
- Holden, Sean; Maksoud, Rebekah; Eaton-Fitch, Natalie; Cabanas, Hélène; Staines, Donald; Marshall-Gradisnik, Sonya (2020-02-18). “A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease”. Journal of Translational Medicine. 18 (1): 290. doi:10.1186/s12967-020-02452-3. PMC 7392668. PMID 32727475.
- Reeves WC, Lloyd A, Vernon SD, Klimas N, Jason LA, Bleijenberg G, Evengard B, White PD, Nisenbaum R, Unger ER (December 2003). “Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution”. BMC Health Services Research. 3 (1): 25. doi:10.1186/1472-6963-3-25. PMC 317472. PMID 14702202.
- “Diagnosis of ME/CFS | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) | CDC”. 15 May 2019. Archived from the original on 28 July 2020. Retrieved 23 May 2020.
- Bansal AS (July 2016). “Investigating unexplained fatigue in general practice with a particular focus on CFS/ME”. BMC Family Practice. 17 (81): 81. doi:10.1186/s12875-016-0493-0. PMC 4950776. PMID 27436349.
- Wyller VB (2007). “The chronic fatigue syndrome – an update”. Acta Neurologica Scandinavica. Supplementum. 187: 7–14. doi:10.1111/j.1600-0404.2007.00840.x. PMID 17419822. S2CID 11247547.
- Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A (December 1994). “The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group”. Annals of Internal Medicine. 121 (12): 953–59. doi:10.7326/0003-4819-121-12-199412150-00009. PMID 7978722. S2CID 510735.
- Holmes GP, Kaplan JE, Gantz NM, Komaroff AL, Schonberger LB, Straus SE, Jones JF, Dubois RE, Cunningham-Rundles C, Pahwa S (March 1988). “Chronic fatigue syndrome: a working case definition”. Annals of Internal Medicine. 108 (3): 387–89. doi:10.7326/0003-4819-108-3-387. PMID 2829679.
- Guideline 53: Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy). London: National Institute for Health and Clinical Excellence. 2007. ISBN 978-1-84629-453-2. Archived from the original on 2014-06-01. Retrieved 2007-09-03.
- Carruthers, Bruce M.; Jain, Anil Kumar; De Meirleir, Kenny L.; Peterson, Daniel L.; Klimas, Nancy G.; Lerner, A. Martin; Bested, Alison C.; Flor-Henry, Pierre; Joshi, Pradip; Powles, A. C. Peter; Sherkey, Jeffrey A.; van de Sande, Marjorie I. (4 December 2011). “Myalgic Encephalomyelitis/Chronic Fatigue Syndrome”. Journal of Chronic Fatigue Syndrome. 11 (1): 7–115. doi:10.1300/J092v11n01_02.
- Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, et al. (October 2011). “Myalgic encephalomyelitis: International Consensus Criteria”. Journal of Internal Medicine. 270 (4): 327–38. doi:10.1111/j.1365-2796.2011.02428.x. PMC 3427890. PMID 21777306.
- “NICE to begin review of its guidance on the diagnosis and treatment of CFS/ME”. NICE. 20 September 2017. Archived from the original on 21 April 2018.
- “Myalgic Encephalomyelitis (“Chronic Fatigue Syndrome”)”. NY DOH diseases and conditions. April 2018. Archived from the original on 2018-04-18. Retrieved 2018-04-21.
- Craig T, Kakumanu S (March 2002). “Chronic fatigue syndrome: evaluation and treatment”. American Family Physician. 65 (6): 1083–90. PMID 11925084. Archived from the original on 2007-09-26. Retrieved 2008-01-25.
- Logan AC, Wong C (October 2001). “Chronic fatigue syndrome: oxidative stress and dietary modifications” (PDF). Alternative Medicine Review. 6 (5): 450–59. PMID 11703165. Archived from the original (PDF) on 2016-11-07. Retrieved 2015-11-12.
Finally, recent evidence suggests celiac disease can present with neurological symptoms in the absence of gastrointestinal symptoms; therefore, celiac disease should be included in the differential diagnosis of CFS.Hakim, Alan; De Wandele, Inge; O’Callaghan, Chris; Pocinki, Alan; Rowe, Peter (March 2017). “Chronic fatigue in Ehlers-Danlos syndrome-Hypermobile type”. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 175 (1): 175–80. doi:10.1002/ajmg.c.31542. PMID 28186393. Archived